KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 78 filers reported holding KEZAR LIFE SCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $411,074 | -9.7% | 345,440 | +85.9% | 0.00% | – |
Q2 2023 | $455,379 | +2.2% | 185,869 | +30.6% | 0.00% | – |
Q1 2023 | $445,430 | -54.9% | 142,310 | +1.5% | 0.00% | – |
Q4 2022 | $986,642 | -17.3% | 140,148 | +1.2% | 0.00% | – |
Q3 2022 | $1,193,000 | +21.2% | 138,540 | +16.5% | 0.00% | – |
Q2 2022 | $984,000 | -41.5% | 118,889 | +17.6% | 0.00% | -100.0% |
Q1 2022 | $1,681,000 | +12.4% | 101,117 | +13.1% | 0.00% | – |
Q4 2021 | $1,495,000 | +103.1% | 89,403 | +5.0% | 0.00% | – |
Q3 2021 | $736,000 | +50.5% | 85,111 | -5.4% | 0.00% | – |
Q2 2021 | $489,000 | +7.5% | 90,011 | +17.9% | 0.00% | – |
Q1 2021 | $455,000 | +14.6% | 76,316 | +0.4% | 0.00% | – |
Q4 2020 | $397,000 | +7.9% | 75,998 | 0.0% | 0.00% | – |
Q3 2020 | $368,000 | +6.4% | 75,998 | +13.8% | 0.00% | – |
Q2 2020 | $346,000 | +3.0% | 66,774 | -13.1% | 0.00% | – |
Q1 2020 | $336,000 | +138.3% | 76,860 | +119.2% | 0.00% | – |
Q4 2019 | $141,000 | +22.6% | 35,057 | 0.0% | 0.00% | – |
Q3 2019 | $115,000 | -57.6% | 35,057 | 0.0% | 0.00% | – |
Q2 2019 | $271,000 | -45.9% | 35,057 | +24.3% | 0.00% | – |
Q1 2019 | $501,000 | +69.8% | 28,203 | +125.8% | 0.00% | – |
Q4 2018 | $295,000 | +40.5% | 12,490 | +27.8% | 0.00% | – |
Q3 2018 | $210,000 | – | 9,770 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |